• 1. Fe(iii)-mediated isomerization of α,α-diarylallylic alcohols to ketones via radical 1,2-aryl migration?
  Ziyang Deng,Changwei Chen,Sunliang Cui RSC Adv., 2016,6, 93753-93755
• 2. Fate of nitrogen-15 in the subsequent growing season of greenhouse tomato plants (Lycopersicon esculentum Mill) as influenced by alternate partial root-zone irrigation
  Maomao Hou,Fenglin Zhong,Qiu Jin,Enjiang Liu,Jie Feng,Tengyun Wang,Yue Gao RSC Adv., 2017,7, 34392-34400
• 3. Ester-directed orthogonal dual C–H activation and ortho aryl C–H alkenylation via distal weak coordination?
  Manickam Bakthadoss,Tadiparthi Thirupathi Reddy,Vishal Agarwal,Duddu S. Sharada Chem. Commun., 2022,58, 1406-1409
• 4. Emulsion technologies for multicellular tumour spheroid radiation assays?
  Kay S. McMillan,Anthony G. McCluskey,Annette Sorensen,Marie Boyd,Michele Zagnoni Analyst, 2016,141, 100-110
• 5. Dissociation of aryl sulfonyl phthalimide radical anions: relevance to the biological activity of arylsulfonyl amides?
  Abdelaziz Houmam,Emad M. Hamed Chem. Commun., 2012,48, 11328-11330

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azetidines Azetidinecarboxylic acids or derivatives Azetidinecarboxylic acids

tert-butyl 3-[(propan-2-yl)amino]azetidine-1-carboxylate: A Comprehensive Overview

tert-butyl 3-[(propan-2-yl)amino]azetidine-1-carboxylate (CAS No. 1033716-68-5) is a compound of significant interest in the field of organic chemistry and pharmacology. This compound, often referred to as tert-butyl azetidine carboxylate, belongs to the class of azetidines, which are four-membered ring structures with unique chemical properties. The molecule's structure incorporates a tert-butyl group, a propan-2-yl amino group, and a carboxylic acid derivative, making it a versatile compound with potential applications in drug design and synthesis.

Recent studies have highlighted the importance of azetidines in medicinal chemistry due to their ability to form stable ring structures and their potential as scaffolds for bioactive molecules. The tert-butyl substituent in this compound contributes to its lipophilicity, enhancing its ability to cross biological membranes. This property is particularly valuable in drug delivery systems, where membrane permeability is a critical factor. Additionally, the propan-2-yl amino group introduces nitrogen into the molecule, which can participate in hydrogen bonding and other intermolecular interactions, further enhancing its bioactivity.

The synthesis of tert-butyl 3-[(propan-2-yl)amino]azetidine-1-carboxylate involves a multi-step process that typically begins with the preparation of the azetidine ring. This is often achieved through cyclization reactions, such as the reaction of an amino alcohol with a suitable electrophile. The introduction of the tert-butyl and propan-2-yl amino groups is then carried out through nucleophilic substitution or alkylation reactions, depending on the specific synthetic pathway chosen. The final step involves the conversion of the carboxylic acid into its tert-butyl ester, which is achieved through esterification using tert-butanol as a reagent.

From a pharmacological perspective, this compound has shown promise in preclinical studies as a potential modulator of various biological pathways. For instance, research has demonstrated that azetidine derivatives can act as inhibitors of certain enzymes involved in signal transduction pathways. The tert-butyl group enhances the compound's stability and bioavailability, while the propan-2-yl amino group contributes to its ability to interact with target proteins. These properties make it an attractive candidate for further investigation in drug discovery programs targeting conditions such as inflammation, cancer, and neurodegenerative diseases.

One area of active research involving this compound is its potential role in anti-inflammatory therapy. Studies have shown that azetidine derivatives can inhibit the activity of cyclooxygenase (COX) enzymes, which are key players in the inflammatory response. The tert-butyl substituent enhances the compound's selectivity for COX isoforms, reducing off-target effects and improving its therapeutic index. Furthermore, the propan-2-yl amino group allows for fine-tuning of the molecule's pharmacokinetic properties, enabling prolonged residence time at target sites.

In addition to its anti-inflammatory potential, this compound has also been explored for its antioxidant properties. Reactive oxygen species (ROS) are implicated in various pathological conditions, including oxidative stress and cellular damage. The ability of tert-butyl 3-[(propan-2-yl)amino]azetidine-carboxy-late to scavenge ROS suggests that it may have applications in preventing oxidative damage and protecting cells from stress-induced injury.

The development of novel synthetic routes for this compound has also been a focus of recent research efforts. Traditional methods often involve harsh reaction conditions or multiple steps, which can limit scalability and increase production costs. Researchers have therefore sought to develop more efficient and environmentally friendly synthesis strategies. For example, microwave-assisted synthesis has been employed to accelerate reaction rates and improve yields while reducing energy consumption.

Moreover, computational modeling techniques have played a pivotal role in understanding the molecular interactions of this compound with biological targets. Molecular docking studies have provided insights into how the tert-butyl, propan-2-y amino, and carboxylic acid groups contribute to binding affinity and selectivity. These findings have informed iterative rounds of structure-based drug design, leading to improved analogs with enhanced bioactivity.

In conclusion, tert-butyl 3-(propane -2 yl)amino]azetidine-carboxy-late (CAS No: 1033716 -68 -5) represents a promising lead compound in medicinal chemistry due to its unique structural features and diverse biological activities. Its potential applications span across anti-inflammatory therapy, antioxidant defense mechanisms,,and enzyme modulation pathways.. Continued research into its synthetic optimization,, pharmacokinetic profiling,,and preclinical evaluation will be essential for advancing this compound toward clinical development.

• 194032-32-1(tert-butyl (3S)-3-methyl-1,4-diazepane-1-carboxylate)
• 792970-55-9(1-(TERT-BUTOXYCARBONYL)-3-(DIMETHYLAMINO)AZETIDINE)
• 887580-89-4(1-Azetidinecarboxylicacid, 3-[[3-(4-methyl-1-piperazinyl)propyl]amino]-, 1,1-dimethylethyl ester)
• 454703-20-9(tert-Butyl 3-(methylamino)azetidine-1-carboxylate)
• 548762-66-9(tert-butyl (2S,5R)-2,5-dimethylpiperazine-1-carboxylate)
• 887581-35-3(tert-butyl 3-[(3-methoxypropyl)amino]azetidine-1-carboxylate)
• 887581-43-3(tert-butyl 3-{[2-(dimethylamino)ethyl]amino}azetidine-1-carboxylate)
• 887580-82-7(1-Azetidinecarboxylicacid, 3-[[2-(4-methyl-1-piperazinyl)ethyl]amino]-, 1,1-dimethylethyl ester)
• 688363-66-8(tert-butyl 2,6-dimethylpiperazine-1-carboxylate)
• 1152111-14-2((3S,5R)-rel-tert-Butyl 3,5-dimethylpiperazine-1-carboxylate)